PauseRX review

What it is

PauseRX is a direct-to-consumer telehealth platform whose product menu is unusually granular for its size: sermorelin injection and sermorelin troches under Performance; NAD⁺ injection and NAD⁺ troches under Longevity; glutathione injection and glutathione nasal spray under Antioxidant; a GHK-Cu cream under Skin; TriMix, PT-141, sildenafil and tadalafil under Sexual Health; injectable TRT and estradiol under Hormones; and compounded semaglutide, compounded tirzepatide, MIC+B12 and consultations for brand Wegovy, Zepbound and Foundayo under Weight Loss. Despite the brand name it is not positioned as menopause-specific care.

How it works

Asynchronous by default, with the platform noting that some states may require a video or chat element. What distinguishes it is the transparency stack. Its FAQ names PauseRX, Inc. as the legal entity, names Strive Pharmacy at 275 E Baseline Rd #104, Gilbert, Arizona 85233 with a phone number and email as the 503A compounder, and names Beluga Health as the physician-led virtual care platform handling prescriptions. Any of those three can be checked independently, which is a materially different position from a site that says only "a licensed US pharmacy". Billing is at ship rather than at order, which lowers upfront cash exposure. Set against that: no state-by-state coverage list is published despite a nationwide claim, no medical director is named as an individual, the LegitScript badge appears without a certification number for direct lookup, and no corporate physical address is given. And the cancellation terms are severe in their own words — orders begin processing immediately and cannot be changed or cancelled once submitted, with medication non-returnable and non-exchangeable — which for a subscription-shaped purchase is a real risk to price in.

Pricing transparency

Published per molecule on each product page, which is what this board rewards. Sermorelin injection is stated as starting at $349 a month and NAD⁺ injection at starting at $249 a month, with sermorelin troches, NAD⁺ troches, glutathione injection, glutathione nasal spray and a GHK-Cu cream on the same menu. Read "starting at" as literally as it is written: these are entry figures for a personalised prescription, so ask whether the number moves once a provider sets your dose, and ask what the monthly shipment actually contains, because neither vial size nor concentration is stated beside the price. On the weight-loss side, compounded semaglutide is flat at $199 across all doses and compounded tirzepatide starts at $249 — genuinely good structure, since a dose increase does not raise the bill — but those are GLP-1 numbers and neither is a peptide or NAD⁺ price. Insurance is not accepted and HSA/FSA eligibility is not confirmed on the site.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. PauseRX reproduces the disclosure verbatim — compounded medications are patient-specific, compounded in a licensed 503(A) compounding pharmacy, are not FDA-approved and have not been reviewed by the FDA for safety, efficacy or quality — which is more precise than most competitors manage, and it names the 503A facility, so the chain is traceable. On evidence, the menu spans the full range. Sermorelin is a GHRH analogue stimulating your own pituitary, preserving the feedback loop that exogenous growth hormone overrides: a real mechanism whose long-term human outcome data thins out badly beyond short-term IGF-1 changes, and the troche route has less pharmacokinetic support than the injection. Injected, intranasal and sublingual NAD⁺ have no controlled human outcome trials; oral NR and NMN raise a blood level. Glutathione and GHK-Cu have essentially no controlled human outcome data. PT-141 is the exception in the other direction — bremelanotide is an FDA-approved drug for one narrow indication, generalised hypoactive sexual desire disorder in premenopausal women, so a compounded version prescribed to anyone else is off-label use of an approved molecule. Individual results vary.

Pros and watch-outs

The evidence behind what PauseRX prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

• Glutathione: the master antioxidant, and where the evidence actually is

  Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.

• GHK-Cu: the copper peptide between real skincare and overclaim

  A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.

• PT-141 (bremelanotide): the evidence on a research-popular peptide that is actually FDA-approved

  Bremelanotide (Vyleesi) is FDA-approved for HSDD in premenopausal women, with phase-3 trial evidence. A straight read of what's proven — and where off-label use goes beyond it.

How PauseRX compares

A few alternatives worth a look, depending on what you’re optimizing for.

• PRPreventiveMD

  NAD⁺ at a published all-in price from a platform that tells you up front whether it can treat you

  See PreventiveMD →
• PEPeptidesRx

  NAD⁺ buyers who want milligrams and concentration stated, not just a monthly fee

  See PeptidesRx →
• PLPlexusDx

  NAD⁺ at a published all-in monthly price with check-ins and no membership on top

  See PlexusDx →